logo-loader
viewZelira Therapeutics Ltd

Gleneagle / Zelda Therapeutics Gold Ltd Sydney Investor Luncheon Presentation

Gleneagle Gold Ltd / Zelda Therapeutics Gold Ltd Sydney Investor Luncheon Presentation

no_picture_pai.jpg
Gleneagle Gold Ltd / Zelda Therapeutics Gold Ltd Sydney Investor Luncheon Presentation

Quick facts: Zelira Therapeutics Ltd

Price: 0.053 AUD

ASX:ZLD
Market: ASX
Market Cap: $51.21 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Zelira Therapeutics Ltd named herein, including the promotion by the Company of Zelira Therapeutics Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Zelira Therapeutics releases interim data for Phase II...

Zelira Therapeutics Ltd (ASX:ZLD) managing director Dr Richard Hopkins, chairman Osagie Imasogie and clinical trial principal investigator Professor Peter Eastwood, of the University of Western Australia, update Proactive on results from the company’s Phase II clinical trial of medicinal...

5 hours, 3 minutes ago

2 min read